Registry of Lobbyists
AstraZeneca Canada Inc.
| Subject matters | Details | Categories |
|---|---|---|
|
Health, Industry, Research and Development, Taxation and Finance
|
Annual federal Budgets and Budget updates relating to the biopharmaceutical industry.
|
Policies or Program
|
|
Health
|
Bill C-64, An Act Respecting Pharmacare, and related federal health policies and programs.
|
Legislative Proposal, Bill or Resolution, Policies or Program
|
|
Economic Development, Health, Research and Development
|
Engagement with the Government regarding the Strategic Innovation Fund (SIF) and investment in Canada.
|
Grant, Contribution or Other Financial Benefit, Policies or Program
|
|
Economic Development, Health, International Trade, Research and Development, Taxation and Finance
|
Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry
|
Policies or Program
|
|
Aboriginal Affairs, Government Procurement, Health
|
Federally-funded Public Drug Plans, including the Non Insured Health Benefits program, with respect to reimbursement for drug products for beneficiaries.
|
Policies or Program
|
|
Health, Research and Development
|
Implementation of the National Strategy for Drugs for Rare Diseases.
|
Policies or Program
|
|
Intellectual Property, International Trade
|
Patent Act, Patented Medicines (Notice of Compliance) Regulations, Data Protection Regulation, Certificates of Supplementary Protection and related policies regarding the regulation of intellectual property for biopharmaceutical products, and maintaining international competitiveness.
|
Regulation
|
|
Health, Industry, Research and Development
|
Patented Medicine Prices Review Board (PMPRB) regarding development and implementation of guidelines to operationalize regulatory amendments.
|
Policies or Program
|
|
Government Procurement, Health, Research and Development
|
Public health and prevention programs including the Public Health Agency of Canada and efforts to support the development and procurement of innovative vaccines and therapies to address major public health issues such as COVID-19 and RSV.
|
Policies or Program
|
|
Health, International Development, Research and Development
|
Regulations, policies and programs related to the review and reimbursement processes of Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance.
|
Policies or Program
|
|
Industry, International Development, Taxation and Finance
|
Scientific Research and Experimental Development (SR&ED) Tax Incentive Program regarding eligible expenditures. Discussions on policies such as "patent box" and Investment Tax Credits.
|
Policies or Program
|
|
Health, Industry, Research and Development, Science and Technology
|
Updates to, and implementation of, the Biomanufacturing and Life Sciences Strategy to support investments in Canada.
|
Policies or Program
|